Webster Bank, N. A. Ardelyx, Inc. Transaction History
Webster Bank, N. A.
- $946 Million
- Q2 2025
A detailed history of Webster Bank, N. A. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Webster Bank, N. A. holds 2,000 shares of ARDX stock, worth $9,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 1,600
25.0%
Holding current value
$9,260
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$116 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$81.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$69.4 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$51.7 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$47.1 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $716M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...